Clindamycin
Product Images NDC 17478-121

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Clindamycin (NDC 17478-121). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Akorn, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Cli0c 0013 01)

Chemical structure diagram of clindamycin, showing a detailed molecular arrangement with labeled carbon, hydrogen, oxygen, nitrogen, chlorine, sulfur, and phosphorus atoms.*

FDA Label Image

Principal Display Panel Text For Container Label: (Cli0c 0013 02)

Clindamycin in 5% Dextrose Injection 300 mg/50 mL single dose bottle by Akorn. The label indicates intravenous use, sterile and nonpyrogenic, with storage instructions at 20° to 25°C. It lists active and inactive ingredients, cautions against rapid injection or IV push, and advises not to add supplementary medications or use in series connections.*

FDA Label Image

Principal Display Panel Text For Carton Label: (Cli0c 0013 03)

Label for Clindamycin in 5% Dextrose Injection 300 mg/50 mL intravenous solution by Akorn. It indicates a sterile, nonpyrogenic single dose 50 mL bottle with storage instructions at 20° to 25°C. The label displays active and inactive ingredients, dosage form, cautionary notes, the NDC code 17478-120-50, and distributor details for Akorn Operating Company LLC.*

FDA Label Image

Principal Display Panel Text For Container Label: (Cli0c 0013 04)

Label for Clindamycin in 5% Dextrose Injection, 600 mg/50 mL, sterile intravenous solution by Akorn Operating Company LLC. The label includes active and inactive ingredients, storage instructions, usage cautions, and a barcode. The product is supplied in a single-dose 50 mL bottle for intravenous use only.*

FDA Label Image

Principal Display Panel Text For Carton Label: (Cli0c 0013 05)

Label for Clindamycin in 5% Dextrose Injection, 600 mg/50 mL, sterile nonpyrogenic solution for intravenous use. It is supplied by Akorn Operating Company LLC in a 50 mL single-dose bottle. The label includes storage instructions, active and inactive ingredients, and cautions about use.*

FDA Label Image

Principal Display Panel Text For Container Label: (Cli0c 0013 06)

Clindamycin in 5% Dextrose Injection 900 mg/50 mL vial label for intravenous use. It is supplied as a 50 mL single-dose bottle by Akorn Operating Company LLC. The label includes active ingredient and inactive ingredients, storage instructions, cautions, and dosage information.*

FDA Label Image

Principal Display Panel Text For Carton Label: (Cli0c 0013 07)

Packaging label for Clindamycin in 5% Dextrose Injection 900 mg/50 mL by Akorn. The label indicates a 50 mL single dose bottle for intravenous use. It includes dosage form and concentration, storage instructions, active and inactive ingredients, and cautions. The label features the NDC 17478-122-50 and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.